|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2950 CAD | 0.00% |
|
-9.23% | +15.69% |
| 04-29 | Vext Science, Inc., Q4 2025 Earnings Call, Apr 29, 2026 | |
| 04-29 | Vext Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Company Valuation: Vext Science, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 69.14 | 26.42 | 47.76 | 28.38 | 46.69 | 53.92 | - | - |
| Change | - | -61.79% | 80.79% | -40.58% | 64.53% | 15.5% | - | - |
| Enterprise Value (EV) 1 | 76.78 | 58.63 | 77.63 | 63.27 | 46.69 | 64.57 | 49.21 | 37.06 |
| Change | - | -23.63% | 32.4% | -18.51% | -26.21% | 38.3% | -23.79% | -24.69% |
| P/E ratio | - | - | 7.07x | -1.43x | -2.66x | -8.68x | 21.1x | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0x | 0.2x | 0.1x | -0x | - |
| Capitalization / Revenue | 1.86x | 0.75x | 1.37x | 0.79x | 0.91x | 0.8x | 0.75x | 0.67x |
| EV / Revenue | 2.06x | 1.66x | 2.23x | 1.76x | 0.91x | 0.96x | 0.68x | 0.46x |
| EV / EBITDA | 5.73x | 3.88x | 14x | 6.91x | - | 5.77x | 2.38x | 1.56x |
| EV / EBIT | - | - | -9.9x | -5.66x | - | -14.7x | 8.79x | - |
| EV / FCF | -10.8x | -20x | 46x | 34.7x | - | 8.86x | 2.67x | 1.88x |
| FCF Yield | -9.25% | -5.01% | 2.17% | 2.88% | - | 11.3% | 37.5% | 53.1% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | 0.041 | -0.115 | -0.0958 | -0.034 | 0.014 | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 37.24 | 35.41 | 34.81 | 36 | 51.37 | 67.57 | 72.3 | 80.6 |
| EBITDA 1 | 13.39 | 15.12 | 5.528 | 9.153 | - | 11.2 | 20.7 | 23.8 |
| EBIT 1 | - | - | -7.843 | -11.18 | - | -4.4 | 5.6 | - |
| Net income 1 | - | - | - | - | -17.99 | -7.079 | 3.241 | -1.209 |
| Net Debt 1 | 7.635 | 32.22 | 29.88 | 34.89 | - | 10.64 | -4.715 | -16.86 |
| Reference price 3 | 0.6400 | 0.2400 | 0.2900 | 0.1650 | 0.2550 | 0.2950 | 0.2950 | 0.2950 |
| Nbr of stocks (in thousands) | 136,713 | 148,963 | 217,484 | 247,443 | 251,034 | 251,034 | - | - |
| Announcement Date | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | 29/04/26 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.68x | 0.96x | 5.77x | - | 53.81M | ||
| 11.68x | - | - | - | 151M | ||
| 13.95x | - | - | - | 123M | ||
| -1.18x | 0.65x | 2.88x | - | 93.4M | ||
| -2.15x | 1.06x | 5.76x | - | 88.86M | ||
| Average | 2.72x | 0.89x | 4.80x | 102.16M | ||
| Weighted average by Cap. | 5.33x | 0.88x | 4.62x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- VEXT Stock
- Valuation Vext Science, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















